Latin-America Veterinary Biologics Market Size, Share,Trends, Growth Analysis Report, 2030

Name: Latin-America Veterinary Biologics Market Size, Share,Trends, Growth Analysis Report, 2030
Creator: MarketsandMarkets

Overview Request Sample Pages Request Customization Download PDF

You are viewing: Latin America Veterinary Biologics Market analysis

Part of: Veterinary Biologics Market (Global)

The Latin America Veterinary Biologics Market was valued at $137.55 Million in 2025 and projected to reach to $168.46 Million by 2030, representing a compound annual growth rate of 4.1%. Latin America's veterinary biologics market is positioned for steady growth driven by intensifying livestock operations and rising animal health awareness.

Latin America Veterinary Biologics Market (2025-2030) : Size and Share

CAGR of

USD Million

Latin America Veterinary Biologics Market Trends and Insights

Latin America's veterinary biologics sector is driven by increasing livestock production, rising pet ownership, and growing awareness of animal health management across the region.
In 2025, Latin America accounts for a meaningful share of the global veterinary biologics demand, supported by expanding agricultural economies and strengthening regulatory frameworks. During the forecast period from 2025 to 2030, Latin America is expected to experience steady growth fueled by investments in animal disease prevention and control programs.
Latin America's market expansion reflects rising demand for vaccines, immunologicals, and biologics across both companion and production animals.
The region's growth trajectory, though moderating compared to global rates, underscores Latin America's strategic importance in the veterinary biologics landscape and its potential for sustained market development..

Key Market Statistics

CAGR (2025-2030) 4.1% CAGR
Market Size, 2025 ~USD 137.55 Million
Forecast, 2030 ~USD 168.46 Million
Geography Latin America

Latin America Veterinary Biologics Market Overview

Market Growth Trajectory :

Latin America's veterinary biologics market is expanding at a CAGR of 4.1%, growing from USD 137.55 million in 2025 to USD 168.46 million by 2030, outpacing several developed regions despite being below the global average of 5.2%.

Livestock Production Expansion :

Rising livestock production across Latin America, particularly in Brazil, Mexico, and Argentina, is driving demand for veterinary biologics including vaccines, immunologics, and diagnostic biologics to ensure herd health and productivity.

Pet Ownership Surge :

Increasing pet ownership and urbanization in Latin American countries are creating new market opportunities for companion animal biologics, with growing consumer spending on pet healthcare and preventive treatments.

Regional Market Consolidation :

Brazil and Mexico represent the largest markets in Latin America, collectively accounting for a significant portion of regional demand, while Rest of Latin America shows emerging growth potential in veterinary biologics adoption.

Latin America Veterinary Biologics Market Dynamics

The region's agricultural sector, particularly in Brazil and Mexico, continues to invest in disease prevention and biosecurity measures, supporting biologics adoption.
Expanding middle-class pet ownership and increased veterinary spending in urban centers further bolster market expansion.
However, growth remains moderate compared to global rates due to regulatory complexities, limited market penetration in rural areas, and price sensitivity among smaller producers. Looking ahead to 2030, Latin America's veterinary biologics sector will benefit from improved distribution networks, regulatory harmonization efforts, and technology transfer from developed markets.
Investment in animal health infrastructure and rising government support for livestock productivity will accelerate biologics uptake.
The market's 4.1% CAGR reflects a maturing regional market with significant untapped potential in emerging segments and underserved geographic areas..

Related Ecosystem

Animal Health

Top Technologies

Polymerase Chain Reaction (PCR) Tests
Porcine
Immunodiagnostics
Lateral Flow Assays
Microarrays

Top Companies

Zoetis Inc.
Patterson Companies, Inc.
Virbac
Elanco Animal Health Incorporated
BOEHRINGER INGELHEIM GMBH

Key Takeaways

Latin America's veterinary biologics market is valued at USD 137.55 million in 2025 and will reach USD 168.46 million by 2030, growing at a 4.1% CAGR.
Latin America's market growth is driven by expanding livestock industries, rising companion animal ownership, and strengthened disease prevention initiatives.
Latin America represents a stable, mid-growth market within the global veterinary biologics sector with increasing regulatory maturity.
Latin America's forecast period (2025�2030) will see sustained demand for vaccines and immunological products across agricultural and companion animal segments.

Veterinary Biologics Market Report Scope

Report Metric	Details
Base Year	2025
Fastest Growing Segment	CANINE (Type)
Forecast Period	2025�2030
Growth Rate	CAGR of 5.2% from 2025 to 2030
Largest Segment	INJECTABLE ROUTE OF ADMINISTRATION (Route Of Administration)
Market Size Base Year (Billions)	~USD 2.72 (2025)
Revenue Forecast (Billions)	~USD 3.51 (2030)
Segments Covered	Product Type, Animal Type, Type, Route Of Administration, Application, End User

Latin America Veterinary Biologics Market Report Segmentation

6 segment dimensions are covered across the global market.

By Product Type

Diagnostic Kits
Immunodmodulators & Immunostimulants
Immunoglobulins & Antitoxins
Immunomodulators & Immunostimulants
Immuoglobulins & Antitoxins
Monoclonal Anitbodies
Monoclonal Antibodies

By Animal Type

Companion Animal
Companion Animals
Livestock Animal
Livestock Animals

By Type

Bovine
Canine
Equine
Feline
Intramuscular Route Of Administration
Intravenous Route Of Administration
Other Injectable Route Of Administration
Porcine
Poultry
Small Ruminant
Subcutaneous Route Of Administration

By Route Of Administration

Injectable Route Of Administration
Oral Route Of Administration
Other Routes Of Administration

By Application

Dermatology
Diagnostic Testing
Diagnostic Tetsing
Infectious Disease Prevention
Oncology
Other Applications
Pain Management

By End User

Other End Users
Veterinary Diagnostic Labs
Veterinary Hospitals & Clinics

Target Audience

Veterinary Biologics Manufacturers : Manufacturers need Latin America-specific market data to identify growth opportunities, optimize product portfolios for regional preferences, and develop localized commercialization strategies for vaccines and immunologics.
Livestock Producers & Agribusinesses : Large-scale livestock operators require insights into biologics market trends to make informed procurement decisions, evaluate supplier options, and plan herd health management investments across Latin America.
Veterinary Distributors & Retailers : Regional distributors need market forecasts and country-level data to optimize inventory management, identify high-growth segments, and align distribution networks with emerging demand patterns in Latin America.
Investment & Private Equity Firms : Investors evaluating Latin America's animal health sector require detailed market sizing and growth projections to assess investment opportunities, identify acquisition targets, and evaluate portfolio company performance.
Regulatory & Government Bodies : Regional health authorities and agricultural ministries use market intelligence to develop animal health policies, assess biosecurity needs, and allocate resources for veterinary infrastructure development across Latin America.

Key Companies in the Latin America Veterinary Biologics Market

Company	HQ	Ownership	Strongest segments
IDEXX	United States	Public Company	Companion Animal Group (in-clinic diagnostics, reference labs, services, software),Water Quality Products,Livestock, Poultry and Dairy (including related diagnostics),
ELANCO	United States	Public Company	Companion animal parasiticides (Seresto, K-9 Advantage, Advantix, Advocate, Credelio Family, Interceptor Plus, Drontal),Companion animal vaccines and therapeutics (Galliprant, Atopica, Milbemax, Onsior, Tru Family),Farm animal feed additives and productivity enhancers (Rumensin, Experior, Hemicell, Surmax, Pulmotil),
MERCK & CO., INC.	United States	Public Company	Oncology (Keytruda, Keytruda Qlex, Welireg, ADC collaborations),Vaccines (Gardasil, pediatric and adult vaccines including Vaxneuvance, Capvaxive),Cardiovascular, pulmonary hypertension and specialty (Winrevair, Adempas/Verquvo, Ohtuvayre, others),
THERMO FISHER SCIENTIFIC INC.	United States	Public Company	Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
NEOGEN CORPORATION	United States	Public Company	Food Safety diagnostics, media, and sanitation,Animal Safety instruments, care products, and biosecurity,Genomics services for livestock and companion animals,
BIO-RAD LABORATORIES, INC.	United States	Public Company	Clinical Diagnostics,Life Science Research Instruments and Systems,Life Science Reagents and Consumables,
IMMUCELL CORPORATION	United States	Public Company	First Defense (core scours prevention),Tri-Shield First Defense,Dual-Force First Defense and related formulations,

IDEXX

IDEXX is a public company founded in 1983 and headquartered in the United States, employing 11,000 people.

ELANCO

Elanco is a public company founded in 1954 in the United States with 9,650 employees.

MERCK & CO., INC.

Merck & Co., Inc. is a public pharmaceutical company founded in 1891 and based in the United States, with 74,000 employees.

THERMO FISHER SCIENTIFIC INC.

Thermo Fisher Scientific Inc. is a public company founded in 1956 in the United States and employs 125,000 people.

NEOGEN CORPORATION

Neogen Corporation is a public company founded in 1981 in the United States with 2,974 employees.

BIO-RAD LABORATORIES, INC.

Bio-Rad Laboratories, Inc. is a public company founded in 1952 in the United States and employs 7,450 people.

IMMUCELL CORPORATION

ImmuCell Corporation is a public company founded in 1982 in the United States with 73 employees.

Countries within Latin America - compare and drill down

Country	2025 size (native)
Brazil	USD 42.03 Million
Mexico	USD 25.92 Million
Rest Of Latin America	USD 18.88 Million

Country market size visualization

Brazil

USD 42.03 Million

Mexico

USD 25.92 Million

Rest Of Latin America

USD 18.88 Million

Reasons to Buy this Report

Regional Market Segmentation : Gain detailed insights into Latin America's veterinary biologics landscape with country-level breakdowns for Brazil, Mexico, and Rest of Latin America, enabling targeted market entry and expansion strategies.
Growth Driver Analysis : Understand the specific factors propelling Latin America's 4.1% CAGR, including livestock intensification, pet ownership trends, and regulatory developments unique to the region.
Competitive Positioning : Benchmark Latin America's growth rate (4.1%) against global performance (5.2%) and identify market gaps, competitive opportunities, and underserved segments for strategic investment.
Forecast Accuracy : Access reliable 2025-2030 projections specific to Latin America's market dynamics, enabling confident business planning, resource allocation, and revenue forecasting for regional operations.
Strategic Market Intelligence : Leverage comprehensive data on Latin American veterinary biologics demand patterns to inform product development, distribution partnerships, and go-to-market strategies tailored to regional needs.

Frequently asked questions

What is the current size of the veterinary biologics market in Latin America?

In 2025, Latin America's veterinary biologics market is valued at USD 137.55 million and is expected to grow to USD 168.46 million by 2030.

What is the projected growth rate for Latin America's veterinary biologics market?

Latin America's veterinary biologics market is projected to grow at a compound annual growth rate (CAGR) of 4.1% from 2025 to 2030.

What are the primary drivers of growth in Latin America's veterinary biologics sector?

Latin America's market growth is driven by increased livestock production, rising pet ownership, expanding disease prevention programs, and strengthening regulatory frameworks across the region.

Which product segments dominate Latin America's veterinary biologics market?

In Latin America, vaccines and immunological products represent the largest segments, serving both production animals and companion animal markets.

How does Latin America's veterinary biologics market compare to global growth?

Latin America's 4.1% CAGR is slightly lower than the global 5.2% CAGR, reflecting a more moderate but stable growth trajectory within the region.

RESEARCH METHODOLOGY

This study extensively used both primary and secondary sources. The research process examined various factors affecting the industry to identify segmentation types, industry trends, key players, competitive landscape, market dynamics, and strategies of major players.

Secondary Research

This research involved the use of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was employed to gather information for an extensive, technical, market-focused, and commercial analysis of the veterinary biologics market. It also helped obtain crucial details about key players, market classification, and segmentation based on industry trends at the most detailed levels, as well as significant developments related to market and technology perspectives. Additionally, a database of major industry leaders was created using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Primary sources from the supply side include project managers, sales managers, marketing managers, business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the veterinary biologics market. Primary sources from the demand side consist of professionals from veterinary hospitals and clinics, diagnostic labs, academic and research institutes, and pet owners.

A breakdown of the primary respondents is provided below:

Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The total size of the veterinary biologics market was determined through data triangulation from three different approaches, as outlined below. After each approach, a weighted average was calculated based on the level of assumptions used in each method.

Data Triangulation

After defining the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown methods were used where applicable to complete the overall market analysis and determine accurate statistics for all segments and subsegments. The following figure illustrates the market validation, source structure, and data triangulation approach used in the market analysis process.

Market Definition

The veterinary biologics market includes all USDA-regulated biologic products, such as monoclonal antibodies, immunoglobulins, immunomodulators, and diagnostic kits, which are used for the prevention, diagnosis, or treatment of animal diseases. These products serve companion animals, livestock, and poultry across veterinary clinics, hospitals, diagnostic labs, and farm or herd settings, enabling veterinarians and animal health professionals to provide targeted immune-based interventions and rapid diagnostic testing. This allows infected animals to be identified quickly for faster treatment, containment, or herd management decisions.

Stakeholders

Veterinary Biologics Manufacturers
Animal Healthcare Product Manufacturers
Veterinary Biologics Distributors and Wholesalers
Animal Welfare Associations
Veterinary Clinics and Care Centers
Research And Consulting Firms
Veterinary Research and Development Organizations
Contract Manufacturing Organizations
Venture Capitalists

Report Objectives

To define, describe, and forecast the veterinary biologics market by product type, animal type, route of administration, application, end user, and region.
To provide detailed information about the key factors, such as drivers, restraints, opportunities, challenges, and industry trends, influencing the market growth
To strategically analyze the regulatory scenario, value chain analysis, supply chain analysis, Porter’s Five Forces analysis, ecosystem analysis, trade analysis, pricing analysis, patent analysis, impact of AI on veterinary biologics market, case study analysis, adjacent market analysis, unmet needs/end user expectations in veterinary biologics market, and trends/disruption impacting customer business in the market
To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To strategically analyze the market in five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies
To track and analyze competitive developments such as product launches and approvals, partnerships, and expansions in the market

Get the Full Veterinary Biologics Market Report

Full forecast, segment splits, and company analysis for all Veterinary Biologics Market.

Download Sample Pages Buy Report

REPORT COVERAGE

＋

Report Description
Market Overview
Market Dynamics
Related Ecosystem
Key Takeaways
Market Scope
Report Segmentation
Target Audience
Key Companies

Market Size in	USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered	Value (USD MN)